Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | ||||||
{[ item.p_purity ]} | {[ item.pr_size ]} | Inquiry |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price) ]} |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price) ]} | {[ item.pr_usastock ]} | in stock Inquiry - | {[ item.pr_chinastock ]} | {[ item.pr_remark ]} in stock Inquiry - | Login | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
CAS No. : | 327183-32-4 | MDL No. : | MFCD12198125 |
Formula : | C10H10O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | ZYKTXRDSAFQAAM-UHFFFAOYSA-N |
M.W : | 162.19 | Pubchem ID : | 22265336 |
Synonyms : |
|
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
60% | With n-butyllithium; In tetrahydrofuran; N-methyl-acetamide; | 8-Chromanylacetic acid can be prepared in three stages from chroman, with an overall yield of 60%, as illustrated by Synth. Comm., 12, 763-70 (1982). On treatment with n-butyllithium and then with dimethylformamide in tetrahydrofuran, chroman results in 8-chromanal, which is then treated with trimethylsilyl cyanide in the presence of zinc iodide in dichloromethane. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
41% | In tetrahydrofuran; at -20 - 5℃; for 5.5h; | Step C - Synthesis of Compound 21 D; To a solution of compound 21C (25.89 mmol) in 10 mL of methanol and 10 mL of THF at 0 0C was added a solution of ethyl azido acetate (10.0g, 77.69 mmol) in 10 mL of methanol. The reaction was cooled to -20 C, and a solution of freshly prepared sodium methoxide in methanol (prepared by dissolving 1.78 g sodium in 80 mL of methanol) was added dropwise (the internal temperature was kept below 5C). The reaction mixture was stirred at approximately 5 C for 0.5 hours, and then stirred at 0 C for 5 hours. The reaction was quenched with aqueous saturated ammonium chloride solution (20 mL), then ethyl acetate (400 mL) and water (80 mL) were added, and the layers separated. The organic layer was <n="147"/>washed with brine (80 mL), dried over magnesium sulfate, filtered and concentrated in vacuo. The crude product obtained was purified on a Biotage 75-M column (gradient: 0 to 25% ethyl acetate in hexanes) to provide compound 21D (2.68 g, 41 %). 1H NMR (400 MHz, CDC13):5 8.00 (d, J= 8.1 Hz, IH), 7.35 (s, IH), 7.02 (d, J= 8.1 Hz, IH), 6.86 (t, J= 7.7 Hz, IH), 4.25 (t, J= 5.1 Hz, 2H), 3.81 (s, 3H), 2.79 (t, J= 6.2 Hz, 2H), 2.03 - 1.97 (m, 2H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
88% | Step B - Synthesis of Compound 21 C; To a solution of compound 21B (10.9 g, 29.23 mmol) in dry THF (240 mL) and hexanes (40 mL) under anhydrous atmosphere at -78 0C, was added n-butyl lithium (20 mL of a 2.5M solution in toluene) dropwise. During the addition, the internal temperature of the solution was kept below 5 0C. The reaction mixture was stirred at approx. 5 C for 4 hours before a slow addition of additional n-butyl lithium (5.8 mL of a 2.5M solution in toluene diluted into 20 ml hexanes). The resulting mixture was stirred at 5 0C for 0.5 hours, followed by an addition of a solution of dimethyl formamide (3.38 mL, 43.84 mmol) in 10 mL of THF. The reaction mixture was stirred at 5 C for 10 minutes, then was warmed to room temperature and stirred for an additional 0.5 hours, and quenched with aqueous 1 N HCl solution (100 mL). The layers were separated, and the aqueous layer was extracted with ether (3 x 200 mL). The combined organic layers were washed with brine (100 mL), dried over magnesium sulfate, filtered and concentrated in vacuo. The resulting residue was purified by column chromatography using a Biotage 75-M silica gel column (gradient: 0 to 20 % ethyl acetate in hexanes) to provide compound 21C (4.20 g, 88 %). 1H NMR (400 MHz, CDC13): delta 10.41 (s, IH), 7.64 & 7.63 (dd, J= 1.5 Hz, 8.1 Hz, IH), 7.25 (d, J= 5.13 Hz, IH), 6.89 (t, J= 7.3 Hz, IH), 4.30 (t, J= 5.1 Hz, 2H), 2.83 (t, J= 6.2 Hz, 2H), 2.09 - 2.03 (m, 2H). |
[ 196799-45-8 ]
2,3-Dihydrobenzofuran-7-carbaldehyde
Similarity: 0.86
[ 55745-70-5 ]
2,3-Dihydrobenzofuran-5-carbaldehyde
Similarity: 0.86
[ 209256-42-8 ]
2,3-Dihydrobenzofuran-4-carbaldehyde
Similarity: 0.86